Antibe Therapeutics Inc. (TSE:ATE – Get Free Report)’s stock price rose 13.5% during mid-day trading on Monday . The stock traded as high as C$0.35 and last traded at C$0.30. Approximately 167,044 shares were traded during trading, an increase of 23% from the average daily volume of 135,475 shares. The stock had previously closed at C$0.26.
Antibe Therapeutics Price Performance
The stock has a market capitalization of C$15.64 million, a PE ratio of -0.84 and a beta of 0.19. The company has a debt-to-equity ratio of 0.29, a quick ratio of 9.58 and a current ratio of 10.06. The company’s fifty day simple moving average is C$0.30 and its two-hundred day simple moving average is C$0.60.
Antibe Therapeutics Company Profile
Antibe Therapeutics Inc, a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs).
Further Reading
- Five stocks we like better than Antibe Therapeutics
- 3 Warren Buffett Stocks to Buy Now
- How to Invest in Silver: A Beginner’s Guide
- 5 Top Rated Dividend Stocks to Consider
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Following Congress Stock Trades
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
